Literature DB >> 15452868

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).

Gregor K Wenning1, François Tison, Klaus Seppi, Cristina Sampaio, Anja Diem, Farid Yekhlef, Imad Ghorayeb, Fabienne Ory, Monique Galitzky, Tommaso Scaravilli, Maria Bozi, Carlo Colosimo, Sid Gilman, Clifford W Shults, Niall P Quinn, Olivier Rascol, Werner Poewe.   

Abstract

We aimed to develop and validate a novel rating scale for multiple system atrophy (Unified Multiple System Atrophy Rating Scale-UMSARS). The scale comprises the following components: Part I, historical, 12 items; Part II, motor examination, 14 items; Part III, autonomic examination; and Part IV, global disability scale. For validation purposes, 40 MSA patients were assessed in four centers by 4 raters per center (2 senior and 2 junior raters). The raters applied the UMSARS, as well as a range of other scales, including the Unified Parkinson's Disease Rating Scale (UPDRS) and the International Cooperative Ataxia Rating Scale (ICARS). Internal consistency was high for both UMSARS-I (Crohnbach's alpha = 0.84) and UMSARS-II (Crohnbach's alpha = 0.90) sections. The interrater reliability of most of the UMSARS-I and -II items as well as of total UMSARS-I and -II subscores was substantial (k(w) = 0.6-0.8) to excellent (k(w) > 0.8). UMSARS-II correlated well with UPDRS-III and ICARS (rs > 0.8). Depending on the degree of the patient's disability, completion of the entire UMSARS took 30 to 45 minutes. Based on our findings, the UMSARS appears to be a multidimensional, reliable, and valid scale for semiquantitative clinical assessments of MSA patients. 2004 Movement Disorder Society.

Entities:  

Mesh:

Year:  2004        PMID: 15452868     DOI: 10.1002/mds.20255

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  155 in total

1.  Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C).

Authors:  Esteban Muñoz; Alex Iranzo; Sebastian Rauek; Francisco Lomeña; Judith Gallego; Doménec Ros; Joan Santamaría; Eduardo Tolosa
Journal:  J Neurol       Date:  2011-06-03       Impact factor: 4.849

Review 2.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

3.  Progressive retinal structure abnormalities in multiple system atrophy.

Authors:  Carlos E Mendoza-Santiesteban; Jose-Alberto Palma; Jose Martinez; Lucy Norcliffe-Kaufmann; Thomas R Hedges; Horacio Kaufmann
Journal:  Mov Disord       Date:  2015-09-11       Impact factor: 10.338

4.  Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.

Authors:  Wolfgang Singer; Ann M Schmeichel; Mohammad Shahnawaz; James D Schmelzer; Bradley F Boeve; David M Sletten; Tonette L Gehrking; Jade A Gehrking; Anita D Olson; Rodolfo Savica; Mariana D Suarez; Claudio Soto; Phillip A Low
Journal:  Ann Neurol       Date:  2020-08-01       Impact factor: 10.422

5.  A cross-sectional study on drug use in multiple system atrophy.

Authors:  María Verónica Rey; Santiago Perez-Lloret; Anne Pavy-Le Traon; Wassilios G Meissner; Francois Tison; Olivier Rascol
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

6.  Hyperintensity of the middle cerebellar peduncles on fluid-attenuated inversion recovery imaging: variation with age and implications for the diagnosis of multiple system atrophy.

Authors:  S Ngai; Y M Tang; L Du; S Stuckey
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

7.  Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.

Authors:  Dusan Roncevic; Jose-Alberto Palma; Jose Martinez; Niamh Goulding; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  J Neural Transm (Vienna)       Date:  2013-12-15       Impact factor: 3.575

8.  Proceedings of the 2nd International Meeting on Multiple System Atrophy, June 17-18, 2004, Rome, Italy.

Authors: 
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

Review 9.  Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study.

Authors:  Wolfgang Singer; Phillip A Low
Journal:  Clin Auton Res       Date:  2015-03-13       Impact factor: 4.435

10.  A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Christopher Grunseich; Angela Kokkinis; Akihiro Hirakawa; Hirohisa Watanabe; Masahiko Yamamoto; Kenneth H Fischbeck; Gen Sobue
Journal:  Neuromuscul Disord       Date:  2015-03-20       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.